My thoughts are that tale over will not occur YET or if it does...

My thoughts are that tale over will not occur YET or if it does then the premium paid will have to be large .
Blocking stakes in register .
I hope that Fuji GvHD Exercise will occur and a premium for other applications ( hence the taken time )
I also wouldn’t be surprised ( and hopeful ) that another significant player ( or institution ) come on to the register .
A placement would not be a bad thing .

We know free funding has been secured for phase 2 trials in some applications. Don’t think for a minute that the NRMC ( govt body - maybe not quite the initials ) didn’t do due diligence before giving a grant .
All the above give the company validation as a significant provider to the stem cell world .

Don’t forget as our market cap grows then we will be on the radar and have to be included in index funds holdings .
Do I have a price target ?
No but I can pretty confidently say over time ( with ups and downs ) that it will be much much higher